Japanese encephalitis virus (JEV) is a mosquito-borne flavivirus found primarily in areas of Asia. The virus has a normal transmission cycle between birds and mosquitoes but also a zoonotic transmission cycle with swine serving as amplifier hosts from which infected mosquitoes transmit the virus to humans. In humans, JEV can cause acute meningioencephalomyelitis, resulting in fatality rates of 5 to 40% (6, 7) . An effective formalin-inactivated vaccine is available, but multiple doses are required to confer protective immunity and some pathogenic side effects have been reported (21, 42) . JEV is thus a continuing public health threat (28, 39) .
The JEV genome is a positive, single-stranded RNA of 10,951 to 10,978 nucleotides (nt) that contains a type 1 5Ј cap but no 3Ј poly(A) tail and undergoes replication entirely in the cytoplasm. The genome contains a single large open reading frame flanked by a 95-nt 5Ј untranslated region (UTR) and a 585-nt 3Ј UTR in the 10,976-nt genome of a majority of JEV strains. The open reading frame is translated as a single polyprotein that undergoes co-and posttranslational processing to yield three structural proteins called capsid (C), premembrane (prM), and envelope (E) and seven nonstructural (NS) proteins called NS1, NS2A/B, NS3, NS4A/B, and NS5 (reviewed in reference 23). Although the details of JEV RNA replication have not yet been characterized, it is thought that most flaviviruses share a common replication strategy (23) . Three viral RNA species found in flavivirus-infected cells have been characterized: a single-stranded 40 to 44S genomic RNA, a double-stranded genome-length replicative form, and a genome-length partially double-stranded replicative intermediate (5, 11, 12, 38, 40) . The minus strand in the replicative form presumably functions as a recycling template for the generation of progeny positive-strand genomes.
Although subgenomic RNAs are not formally thought to be products of the flavivirus replication cycle, some studies have shown the existence of small (8 to 15S) viral RNA species in cell cultures infected with St. Louis encephalitis virus (29) , West Nile virus (WNV) (43) , and JEV (37, 38) , but only those of WNV have been characterized in detail. Wengler and Gross (43) reported that WNV produces RNAs of 6.5 ϫ 10 4 and 4.2 ϫ 10 4 Da (ϳ197 and 127 nt in length, respectively) in BHK-21 cells, but only the larger species was detected in insect cells. The larger species was found to be a virus-specific positivestrand RNA with no cap or poly(A) tail that was inactive as a template in cell-free translation systems. It was postulated that the smaller RNA was probably nonfunctional subgenomic mRNA, but its origin, sequence, and function were not determined. Takegami and Hotta (38) reported a 10S plus-strand RNA species in both JEV-infected C6/36 and Vero cells by Northern analysis using an in vitro-transcribed RNA probe specific to genomic nt 9183 to 10883, but the RNA was not characterized further. Recently, an RNA of 600 nt which hybridizes to a 3Ј-terminal 1.7-kb fragment of Murray Valley encephalitis virus (MVEV) RNA was detected in the brains of infected mice (41); however, its structure, sequence, and function were not addressed.
In addition to the small RNAs, naturally occurring defective interfering RNA replicons (DI RNAs) have been reported for WNV (3, 4, 14) , MVEV (22) , and JEV (33), but only the molecular structure of MVEV DI RNA has been determined (22) . The MVEV DI RNAs present in persistently infected Vero cells were all shown to have in-frame internal deletions of 2.3 to 2.6 kb from the prM, E, and NS1 genes of the virus genome. The DI RNAs had thus retained the presumed terminal replication promoter regions of the viral genome, the entire C gene, and genes for the nonstructural proteins.
In this study, we report a JEV-specific RNA molecule of 521 to 523 nt in both mammalian and mosquito cells infected with any of nine strains of JEV. The small RNA did not have properties of a DI RNA replicon but rather was found to be identical to the 3Ј-terminal 521 to 523 nt of the genome. This sequence represents the highly conserved 3Ј-terminal region in the 3Ј UTRs of all characterized JEV isolates. We thus confirm and extend the observations of Takegami and Hotta (38) by establishing the structure of the small RNA and by showing that it is a consistent product of JEV replication in both mammalian and mosquito cells. We postulate, furthermore, that the small RNA plays a biological role, perhaps as a competitor of the virus genome 3Ј terminus during genome replication.
MATERIALS AND METHODS
Cells and viruses. BHK-21 mammalian cells were grown in RPMI 1640 medium supplemented with 2% fetal bovine serum (Gibco-BRL). C6/36 mosquito cells, derived from Aedes albopictus (18) , were grown in Dulbecco's modified Eagle's medium supplemented with 2% fetal bovine serum (Gibco-BRL). The viruses used were JEV RP-2 and JEV RP-9, mutants selected from a ␥-irradiated strain, JEV NT109, originally isolated from Culex tritaeniorhynchus (10) . JEV TP-53 (Taipei County, Taiwan, 1994), JEV CH-1392 (Chang-Hwa County, Taiwan, 1990), and JEV CC-27 (Chao-Chow, Pingtung County, Taiwan, 1983) were isolates collected from mosquitoes in northern, central, and southern areas of Taiwan, respectively. JEV S-26 (Miao-Li County, Taiwan, 1994) and JEV PC-806 (Chao-Chow, Pingtung County, Taiwan, 1990) were isolated from infected pigs in the indicated counties. The vaccine strains Beijing-1 (China, 1949) and Nakayama (Japan, 1935) were originally isolated from infected human brain (16, 26) . For a majority of the GenBank-catalogued JEV strains, including Beijing-1 and JEV RP9, the genome length is 10,976 nt.
Northern analysis. For studies of BHK-21 cells, cells infected at the appropriate multiplicities of infection (MOI) were incubated at 37°C for 1 h and refed with RPMI 1640 medium supplemented with 2% fetal bovine serum, and total RNA was extracted with Trizol reagent (Invitrogen) at the appropriate times postinfection (at 4-or 8-h intervals from 24 to 48 h postinfection). The yield of cytoplasmic RNA from one 35-mm-diameter dish was ϳ10 g, and 2.5 g was used per lane for formaldehyde-agarose gel electrophoresis as described previously (8, 34) . For studies of C6/36 cells, the same procedure was used as for BHK-21 cells except that the cells were grown at 28°C and infected at an MOI of 0.1, and the cytoplasmic RNA was extracted 5 days postinfection. For probe labeling for Northern analysis, an ϳ100-pmol oligonucleotide was tailed with digoxigenin (DIG)-ddUTP using a DIG Oligonucleotide 3Ј-End Labeling kit (Roche Molecular Biochemicals). Hybridization and chemoluminescence detection of the virus-specific bands with DIG-labeled oligonucleotides were done following the procedures of the manufacturer. Quantitation of the bands was done with the Phoretix (Newcastle upon Tyne, United Kingdom) 1D, version 3.0, imaging system.
Primer extension analysis. The method used for primer extension analysis was that described by Sambrook et al. (32) . Five pmol of 32 P-labeled oligonucleotide 3JEV10543(Ϫ) was coprecipitated in ethanol with 5 g of template RNA, and the dried RNA was dissolved in 10 l of water. The RNA mixture was heated for 5 min at 90°C, incubated at 42°C for 30 min, and further incubated for 1 h at 42°C in a 30-l reaction mixture containing 1ϫ first-strand buffer (Invitrogen), 1 mM deoxynucleoside triphosphates, 30 U of RNasin (Promega), and 200 U of Superscript II (Invitrogen). The extended products were analyzed by electrophoresis on a 6% polyacrylamide gel and imaged using autoradiography. RACE analysis. 5Ј rapid amplification of cDNA ends (RACE) (Invitrogen) was carried out according to the manufacturer's protocol. Cytoplasmic RNA extracted using Trizol agent (Invitrogen) from JEV-infected BHK-21 cells at 48 h postinfection was used as a source of templates. For this, 5 g of RNA was used for first-strand cDNA synthesis with oligonucleotide 3JEV10950(Ϫ), and the cDNA products were C tailed using dCTP and terminal deoxynucleotidyl transferase. Five microliters of C-tailed cDNA was used for PCR amplification (30 cycles of 94°C for 1 min, 55°C for 1 min, and 72°C for 1 min, followed by final extension at 72°C for 7 min) with primer 3JEV10929(Ϫ) and the 5Ј RACE anchor primer. PCR products ϳ520 nt in size were gel purified and subsequently cloned into a pGEM-T Easy vector (Promega) following the manufacturer's instructions. Plasmid DNA was sequenced commercially with an ABI PRISM 377-97 DNA sequencer (Protech Technology Enterprise Co., Ltd.).
Synthetic oligonucleotides. The oligonucleotides used in this study are described in Table 1 .
RNA structure predictions. Higher-order RNA structure predictions were made by the mfold program of M. Zuker (25, 45 ; http://bioinfo.rpi.edu/ϳzukerm/).
Nucleotide sequence accession numbers. JEV genome nucleotide positions correspond to those for JEV RP9 deposited in GenBank under accession number AF014161.
RESULTS
Detection of JEV small-RNA species whose kinetics of appearance parallels that of the genome. Initially, a small viral RNA species ϳ500 nt in length was observed when RNA from JEV RP-9-infected BHK-21 cells was examined 48 h postinfection by Northern analysis with a probe detecting genomic 3Ј-terminal sequence (data not shown). To determine the kinetics of appearance and the relative abundance of the small RNA and the virus genome, cells were infected with JEV RP-9 at an MOI of 0.01 and the RNA was examined at 4-or 8-h intervals through 48 h postinfection, which is near the time of maximal cytopathic effect under these conditions. The probe used was 3JEV10950(Ϫ), which detects RNA containing the very 3Ј-terminal 27 nt of the JEV genome (Table 1 and Fig. 1 ). From Fig. 1, lane 3 , it can be seen that genomic RNA appeared as early as 24 h postinfection, and its abundance continued to increase throughout the 48-h infection period, except for a diminution at 40 h postinfection. The small RNA species appeared as early as 28 h postinfection (Fig. 1, lane 4) and likewise continued to increase in abundance throughout the 48-h infection period. We concluded that the small RNA was of viral origin, since it was not present in mock-infected cells at 48 h (Fig. 1, lane 2) . Furthermore, since the sequence of the small RNA is contained only once in the virus genome (described below), the molar ratios of the small RNAs to genomic RNA at the various times could be determined by a simple ratio analysis of image densities. Thus, the ratios of small RNA to genome ranged from 0.25 at 32 h postinfection to 1.5 at 40 h postinfection (Fig. 1) . The small RNA does not have properties of a DI RNA. To test whether the small RNA was a DI RNA, two experimental approaches were taken. The first was biological and attempted to find a disappearance of the small RNA upon high dilution of the virus inoculum, and conversely, to find an increased inhibition of virus genome replication at lower dilutions of the inoculum. The rationale for this approach was based on the classic observations that DI RNAs lose their competitive advantage over the genome when the DI RNA-containing virus inoculum is diluted (17) . The second approach was a structural analysis to determine whether the termini of the small RNA mimicked the terminal promoter regions of the viral genome.
To measure the potential effects of differing inoculum dilutions on small-RNA and genome abundances, BHK-21 cells were infected with JEV RP-9 at MOI of 1, 0.1, 0.01, and 0.001 and the molar ratios of the small and genomic RNAs were determined 24 and 48 h postinfection. In all, the abundance of the small RNAs relative to the genome stayed within the range of 0.11 to 0.35, indicating that the ratio did not change significantly as a function of the inoculum dilution (data not shown). The ratios also did not deviate from a range of 0.25 to 0.69 when supernatant from a dish inoculated at an MOI of 0.01 was diluted 1,000-fold at each of four 48-h serial passages (data not shown). These results together demonstrated that the small RNA does not behave biologically as a DI RNA.
The structure of the small-RNA species was determined by Northern, primer extension, and 5Ј RACE analyses. For Northern analyses, 16 probes that would variously detect positive or negative strands in the regions of the 3Ј and 5Ј genomic termini and in various regions throughout the genome were used on RNA extracted 48 h postinfection from BHK-21 cells infected with JEV RP-9 at an MOI of 0.01 (the data are summarized in Table 1 ). None of the minus-strand-detecting probes identified a small RNA, whereas they did identify the minus strand of the genome, and only positive-strand-detecting probes mapping downstream of nt 10,453 identified the small RNA. These data together indicated that the small RNA was of plus-strand polarity and was probably located only within the 3Ј UTR.
In primer extension analyses, the radiolabeled oligonucleotide 3JEV10543(Ϫ) was used to determine the map position of the 5Ј termini of the small RNA. The results showed that the 5Ј ends of most small RNA molecules started at nt 10,455 early in infection (28 to 32 h postinfection), and as the infection progressed, two other small RNAs appeared with 5Ј nucleotides terminating at positions 10,454 and 10,456 (Fig. 2) . The largest small-RNA species, therefore, was 523 nt in length.
For complete nucleotide sequence determination of the small RNA, including the 5Ј-most base, the method of 5Ј RACE was used. RACE PCR products ϳ520 nt in size were gel purified and cloned into a pGEM-T Easy vector. Of 12 completely sequenced transformants, 5 contained the predicted insert of ϳ520 nt, with 3 starting at nt 10,455 and 2 starting at nt 10,456. The seven other clones had 5Ј ends starting at distant sites, indicating that they were probably derived from viral genomic RNA. Results from Northern analyses, primer extension, and 5Ј RACE sequencing therefore determined that the small RNA was 521 to 523 nt in length and corresponded to the 3Ј terminus of the genome.
The small RNA is generated in both mammalian and mosquito cells by all JEV isolates tested. The small RNA was initially detected in BHK-21 cells with isolates JEV RP-2 and JEV RP-9 ( Fig. 1 and 3 , and data not shown), both laboratoryderived strains. To determine whether generation of the small RNA in mammalian cells is a general property of JEV and not just a property of laboratory-derived strains, wild-type JEV isolates from various regions of Taiwan, namely, JEV TP-53, JEV CH-1392, JEV CC-27, JEV S-26, and JEV PC-806, were From RNA extracted at 48 h postinfection, it can be seen that the small RNA was generated by each of the five JEV field isolates (Fig. 3, lanes 4 to 8) . In addition, the small RNA was detected in BHK-21 cells infected with the JEV vaccine strains Beijing-1 and Nakayama isolated from China and Japan, respectively (data not shown). These results, therefore, demonstrated that generation of the small RNA is a general property of JEV and is not an idiosyncrasy of laboratory strains of JEV.
To determine whether generation of the small RNA is a special property of mammalian cells, its existence in mosquito cells was sought. Since growth of JEV in C6/36 cells is slower than in BHK-21 cells, RNA for Northern analysis was extracted 5 days postinfection from cells infected with an MOI of 0.1. This is near the time of maximal cytopathic effect in mosquito cells under these conditions. Analysis of both the laboratory strain and five field strains of JEV in mosquito cells demonstrated the generation of the small RNA (Fig. 3, lanes  10 to 16) . Interestingly, the small-RNA/genomic-RNA molar ratios were greater in mosquito cells (ranging from 1.25 to 5.14) than in mammalian cells (ranging from 0.25 to 1.50) when measured at a time just prior to cell death.
DISCUSSION
In this paper, we identify and determine the structure of a small-RNA species generated in JEV-infected cells of mammalian or mosquito origin. The small RNA represents the very 3Ј-terminal 521 to 523 nt of the JEV 585-nt 3Ј UTR and is present in the range of 0.25 to 5.14 molar ratio relative to the virus genome. Because of the cytolytic nature of JEV infection in mammalian cells and the possibility of isopycnic copurification of cellular replication complexes with virions, we were unable to conclusively determine whether the small RNA observed by Northern analysis in purified virion preparations is packaged. Certainly the small RNA was present in material purified by this method (data not shown), but further experimentation will be required to rigorously answer the question of packaging.
What is the origin of the small RNA? Inasmuch as the abundance of the small RNA was not influenced by inoculum dilution, we conclude that it does not represent a defective or DI RNA replicon. This conclusion was supported by its structure, which shows it to represent only the 3Ј-terminal 521 to 523 nt of the virus genome. On the basis of the experiments presented here, we conclude that the small RNA is synthesized de novo in each infection and that the mechanism of its origin is not an idiosyncrasy of any particular JEV strain or host cell type.
We speculate that the small RNA is made either by transcription from a full-length minus strand through an internal promoter or by replication of the viral genome followed by RNase-specific cleavage. The first scenario seems unlikely, since transcripts of this size would require an internal promoter located upstream of nt 10454, and no sequence has been found by inspection that would appear to mimic the 5Ј end of the genome or otherwise suggest a promoter. The second scenario seems more likely, since nt 6 through 56 in the 523-nt RNA are predicted to fold into a stable stem-loop structure (free energy, Ϫ21.2 kcal/mol) (Fig. 4) that could in principle serve as a region of RNase resistance or could associate with viral or cellular protein(s) to form an RNase-resistant complex.
What is the function of the small RNA? Previous studies of JEV infection in mosquito C6/36 cells have shown an early peaking of negative-strand synthesis, i.e., at 12 h postinfection, with subsequent shut-off of minus-strand synthesis and a continued synthesis of positive-strand RNA (38) . A similar temporal regulation of RNA synthesis in porcine kidney cells was not observed, apparently due to extensive rapid cell death (40) . Assuming that early inhibition of minus-strand synthesis is a universal pattern in JEV replication, we suggest that the small RNA described here may play a role in its inhibition.
The 3Ј UTRs of mosquito-borne flaviviruses vary from ϳ400 to 600 nt in length, and within each subgroup, the 3Ј UTR can be divided into a highly variable 5Ј-terminal subdomain and a highly conserved 3Ј-terminal subdomain that in turn harbors a number of conserved higher-order structural elements (15, 24, 27, 30, 31) . In JEV, on the basis of alignment of all 28 GenBank-deposited JEV genome sequences, these subdomains are formed by sequences that are 64 and 521 nt in length, respectively (19, 24, 30) . It is therefore striking that the small RNA precisely represents the highly conserved region of the 3Ј UTR. Based on documented functions of the conserved 3Ј-terminal subdomain in flaviviruses, two functions might be expected for which the small RNA could mechanistically compete. (i) In JEV, an 8-nt cyclization motif is found, mapping at genome nt 10,866 to 10,873, that potentially interacts with genome nt 136 to 143 (15) . A similar interaction in yellow fever virus between genome nt 10,751 to 10,758 and 156 to 163 has been shown to be required for genome replication (13) , and genome cyclization has been shown to be required for replication in Kunjin (20) and dengue (44) viruses.
(ii) A 3Ј-long stable hairpin structure located within the 3Ј-terminal 83 nt interacts with both viral and cellular proteins and is required for RNA synthesis (1, 2, 9, 36). In JEV, viral NS3 and NS5 proteins and the cellular protein Mov 34 bind to the 3Ј long stable hairpin (9, 36) . Thus, in principle, inhibition of either of these functions by the small RNA could lead to a down regulation of minusstrand RNA synthesis and continued synthesis of positivestrand RNA. In recent years, many small noncoding RNA molecules that play novel unpredicted roles in virus replication processes have been found. These include gene silencing, regulation of RNA processing, and regulation of transcription (reviewed in reference 35). It is therefore possible that the JEV small RNA could have an effect on virus production, persistence, or pathogenesis in ways not directly connected to genome replication, as speculated above. Further research is required to determine the biological significance of the JEV small RNA. Certainly its abundance alone implies importance as a regulatory molecule.
